Nagi Bioscience
We are a Swiss high-tech company developing and offering cutting-edge biological testing solutions that enable scientists to generate insights they need to fuel life-changing discoveries in a faster, more efficient, and ethical way. Our technologies are designed to integrate seamlessly into existing lab environments, enhancing efficiency, accuracy, and reproducibility.
Axiom Bio Inc
Axiom is dedicated to empowering scientists to eliminate molecular toxicity by providing the most accurate and affordable predictive models. Leveraging a unique dataset of more than 100,000 molecules tested in pooled primary human liver cells, Axiom’s ML/AI models surpass conventional toxicity screening methods by offering higher sensitivity and specificity in hazard detection. The platform also integrates mechanistic cell-based data (mitochondrial toxicity, ER stress, ROS formation, cytotoxicity, and more) with clinical adverse outcomes to deliver precise risk assessments at relevant exposure levels. Axiom’s ML/AI models run solely on the molecular structure, removing the need for costly physical experiments. As a result, scientists can affordably identify toxic substructures and be guided toward safer molecule design, ultimately accelerating the development of more effective and less toxic therapeutics.
Quris.AI
Quris.AI is transforming drug safety prediction by uniquely combining advanced AI capabilities with cutting edge 3D organ models, enabling predictions with unprecedented accuracy and scalability. our platform has been extensively validated by leading Pharma companies, including a long term collaboration with Merck GmbH. By predicting safety in human relevant 3D models, our platform significantly increases the likelihood of clinical success and reduces significantly the need for animal testing.
CanChip GmbH
We are a commercial provider of a microphysiological system either as a product or service.
TheWell Bioscience
TheWell Bioscience provides xeno-free, 3D cell culture solutions, empowering research in organoids, regenerative medicine, and drug discovery.
VoxCell
VoxCell empowers scientists and drug developers to study drug behavior with unprecedented physiological relevance. With vascular complexity at the core of our innovation, VoxCell delivers human-like models that accelerate therapeutic discovery and bridge the gap between preclinical and clinical phases. Committed to innovation and excellence, VoxCell continues to expand its impact on a global scale.
LifeNet Health
LifeNet Health is the world’s most trusted provider of transplant solutions — from organ recovery and technologically advanced clinical biologics and cellular therapies, to life sciences solutions that support drug discovery and medical innovation.
Bioprinting Laboratories
Bioprinting Labs’ pillar/perfusion plates enable robust and reproducible organoid culture and in situ analysis. Our products streamline organoid-based assays by facilitating miniature organoid culture and enhancing organoid maturity through dynamic culture in the pillar/perfusion plates.
AIM Biotech
AIM Biotech is a leading bioengineering company, offering scalable, cost-effective 3D cell culture platforms, drug screening services, and customized assay development. By combining model realism and platform simplicity, AIM’s plug-and-play technologies empower drug developers to mimic human biology with precision, delivering clinically-relevant data.